BG101193A - New substituted oxazolidinons - Google Patents
New substituted oxazolidinonsInfo
- Publication number
- BG101193A BG101193A BG101193A BG10119397A BG101193A BG 101193 A BG101193 A BG 101193A BG 101193 A BG101193 A BG 101193A BG 10119397 A BG10119397 A BG 10119397A BG 101193 A BG101193 A BG 101193A
- Authority
- BG
- Bulgaria
- Prior art keywords
- oxazolidinons
- new substituted
- asmedicamentous
- thedescription
- substitutents
- Prior art date
Links
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6581—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
- C07F9/6584—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
- C07F9/65842—Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring
- C07F9/65844—Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring the phosphorus atom being part of a five-membered ring which may be condensed with another ring system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19604223A DE19604223A1 (de) | 1996-02-06 | 1996-02-06 | Neue substituierte Oxazolidinone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG101193A true BG101193A (en) | 1999-02-26 |
Family
ID=7784633
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG101193A BG101193A (en) | 1996-02-06 | 1997-02-04 | New substituted oxazolidinons |
Country Status (36)
| Country | Link |
|---|---|
| US (1) | US5792765A (es) |
| EP (1) | EP0789025B1 (es) |
| JP (1) | JPH09316073A (es) |
| KR (1) | KR970061888A (es) |
| CN (1) | CN1160051A (es) |
| AR (1) | AR005703A1 (es) |
| AT (1) | ATE200285T1 (es) |
| AU (1) | AU1251697A (es) |
| BG (1) | BG101193A (es) |
| BR (1) | BR9700885A (es) |
| CA (1) | CA2196862A1 (es) |
| CO (1) | CO4560411A1 (es) |
| CZ (1) | CZ34097A3 (es) |
| DE (2) | DE19604223A1 (es) |
| DK (1) | DK0789025T3 (es) |
| EE (1) | EE9700043A (es) |
| ES (1) | ES2157027T3 (es) |
| GR (1) | GR3036015T3 (es) |
| HR (1) | HRP970048A2 (es) |
| HU (1) | HUP9700358A3 (es) |
| ID (1) | ID15881A (es) |
| IL (1) | IL120125A0 (es) |
| MX (1) | MX9700886A (es) |
| NO (1) | NO970511L (es) |
| NZ (1) | NZ314179A (es) |
| PL (1) | PL318277A1 (es) |
| PT (1) | PT789025E (es) |
| SG (1) | SG50791A1 (es) |
| SI (1) | SI0789025T1 (es) |
| SK (1) | SK15897A3 (es) |
| SV (1) | SV1997000009A (es) |
| TN (1) | TNSN97032A1 (es) |
| TR (1) | TR199700092A2 (es) |
| TW (1) | TW350845B (es) |
| YU (1) | YU4397A (es) |
| ZA (1) | ZA97927B (es) |
Families Citing this family (67)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9601666D0 (en) * | 1996-01-27 | 1996-03-27 | Zeneca Ltd | Chemical compounds |
| HUP0001393A3 (en) * | 1997-05-30 | 2001-07-30 | Upjohn Co | Oxazolidinone antibacterial agents having a thiocarbonyl-functionality and their medical use |
| US6255304B1 (en) | 1997-05-30 | 2001-07-03 | Pharmacia & Upjohn Company | Oxazolidinone antibacterial agents having a thiocarbonyl functionality |
| WO1999012914A1 (fr) * | 1997-09-11 | 1999-03-18 | Hokuriku Seiyaku Co., Ltd. | Derives de thiouree |
| SK286569B6 (sk) * | 1997-11-07 | 2009-01-07 | Pharmacia & Upjohn Company | Spôsob výroby oxazolidinónov |
| DE19802239A1 (de) * | 1998-01-22 | 1999-07-29 | Bayer Ag | Neue mit Bicyclen substituierte Oxazolidinone |
| US6239152B1 (en) | 1998-01-23 | 2001-05-29 | Pharmacia & Upjohn Company | Oxazolidinone combinatorial libraries, compositions and methods of preparation |
| CA2333332A1 (en) * | 1998-06-05 | 1999-12-16 | Astrazeneca Ab | Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them |
| GB9821938D0 (en) * | 1998-10-09 | 1998-12-02 | Zeneca Ltd | Chemical compounds |
| JP2000204084A (ja) * | 1998-11-11 | 2000-07-25 | Hokuriku Seiyaku Co Ltd | チオカルバミド酸誘導体 |
| AU1045300A (en) * | 1998-11-17 | 2000-06-05 | Bayer Aktiengesellschaft | Novel heterocyclyl-substituted oxazolidone derivatives |
| WO2000029396A1 (de) * | 1998-11-17 | 2000-05-25 | Bayer Aktiengesellschaft | Neue substituierte phenyloxazolidon-derivate |
| US6403804B1 (en) | 1998-12-07 | 2002-06-11 | Takasago International Corporation | Process for preparing optically active oxazolidinone derivative |
| DE60004207T2 (de) * | 1999-05-27 | 2004-06-03 | Pharmacia & Upjohn Co., Kalamazoo | Bizyklische oxazolidinone als antibakterielle mittel |
| JP2003513885A (ja) | 1999-07-28 | 2003-04-15 | ファルマシア・アンド・アップジョン・カンパニー | オキサゾリジノンおよび抗感染薬としてのその使用 |
| US6297242B1 (en) | 1999-08-12 | 2001-10-02 | Ortho-Mcneil Pharmaceutical, Inc. | N-substituted amidine and guanidine oxazolidinone antibacterials and methods of use thereof |
| US6608081B2 (en) | 1999-08-12 | 2003-08-19 | Ortho-Mcneil Pharmaceutical, Inc. | Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods |
| US6413981B1 (en) | 1999-08-12 | 2002-07-02 | Ortho-Mcneil Pharamceutical, Inc. | Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods |
| GB9928568D0 (en) | 1999-12-03 | 2000-02-02 | Zeneca Ltd | Chemical compounds |
| US6518285B2 (en) | 1999-12-21 | 2003-02-11 | Ortho Mcneil Pharmaceutical, Inc. | Piperidinyloxy and pyrrolidinyloxy oxazolidinone antibacterials |
| ES2201625T3 (es) | 1999-12-23 | 2004-03-16 | Hans-Peter Wilfer | Recipiente para instrumentos musicales, especialmente para guitarras. |
| DE19962924A1 (de) | 1999-12-24 | 2001-07-05 | Bayer Ag | Substituierte Oxazolidinone und ihre Verwendung |
| KR100355345B1 (ko) * | 2000-01-21 | 2002-10-12 | 한국과학기술연구원 | 티오펜환을 함유한 신규한 옥사졸리디논 유도체, 그의 제조방법 및 조성물 |
| US6514529B2 (en) | 2000-03-22 | 2003-02-04 | Pharmacia & Upjohn Company | Oxazolidinone tablet formulation |
| MY127336A (en) * | 2000-03-22 | 2006-11-30 | Upjohn Co | Container for linezolid iv solution |
| PE20011124A1 (es) | 2000-03-31 | 2001-10-28 | Upjohn Co | Nuevos agentes antibacterianos de benzosultam oxazolidinona |
| GB0009803D0 (en) * | 2000-04-25 | 2000-06-07 | Astrazeneca Ab | Chemical compounds |
| DK1301207T3 (da) | 2000-06-30 | 2005-10-10 | Pharmacia & Upjohn Co Llc | Sammensætninger til behandling af bakterieinfektioner indeholdende en oxazolidinonforbindelse, sulbactam og ampicillin |
| PE20030044A1 (es) * | 2000-11-17 | 2003-02-09 | Upjohn Co | Isoxazolinonas biciclicas de formula i |
| EP1358185A2 (en) * | 2001-02-07 | 2003-11-05 | Ortho-Mcneil Pharmaceutical, Inc. | Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods |
| DE10129725A1 (de) | 2001-06-20 | 2003-01-02 | Bayer Ag | Kombinationstherapie substituierter Oxazolidinone |
| TW200302095A (en) * | 2002-01-25 | 2003-08-01 | Upjohn Co | Oxazolidinone cotherapy |
| US7141588B2 (en) * | 2002-02-25 | 2006-11-28 | Pfizer, Inc. | N-aryl-2-oxazolidinone-5-carboxamides and their derivatives |
| AR038536A1 (es) * | 2002-02-25 | 2005-01-19 | Upjohn Co | N-aril-2-oxazolidinona-5- carboxamidas y sus derivados |
| KR20040095328A (ko) * | 2002-03-29 | 2004-11-12 | 파마시아 앤드 업존 캄파니 | 당뇨병성 족감염증을 치료하기 위한 옥사졸리디논의비경구, 정맥내 및 경구 투여방법 |
| CA2491287A1 (en) * | 2002-08-12 | 2004-02-19 | Pharmacia & Upjohn Company | N-aryl-2-oxazolidinones and their derivatives |
| WO2004026848A1 (en) * | 2002-09-20 | 2004-04-01 | Lupin Limited | Oxazolidinone derivatives, process for their preperation and their use as antimycobacterial agents |
| AR043050A1 (es) * | 2002-09-26 | 2005-07-13 | Rib X Pharmaceuticals Inc | Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos |
| BR0316483A (pt) * | 2002-11-21 | 2005-10-11 | Upjohn Co | Derivados de n-(4-(piperazin-1-il)-fenil-2-oxazolidinona-5-carboxami da e compostos relacionados como agentes antibacterianos |
| DE10300111A1 (de) * | 2003-01-07 | 2004-07-15 | Bayer Healthcare Ag | Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid |
| JP2006516991A (ja) * | 2003-02-07 | 2006-07-13 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | 抗菌剤 |
| BRPI0407304A (pt) * | 2003-02-07 | 2006-01-10 | Warner Lambert Co | Agentes antibacterianos |
| US7012088B2 (en) * | 2003-02-24 | 2006-03-14 | Pharmacia & Upjohn Company | Indolone oxazolidinones and derivatives thereof |
| US20040204463A1 (en) * | 2003-04-01 | 2004-10-14 | Harris Christina Renee | N-aryl-2-oxazolidinone-5-carboxamides and their derivatives |
| JP2007503426A (ja) * | 2003-08-25 | 2007-02-22 | ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー | 新規な抗微生物性アリールオキサゾリジノン化合物 |
| US7304050B2 (en) * | 2003-09-16 | 2007-12-04 | Pfizer Inc. | Antibacterial agents |
| DE10355461A1 (de) | 2003-11-27 | 2005-06-23 | Bayer Healthcare Ag | Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung |
| WO2005082900A2 (en) * | 2004-01-28 | 2005-09-09 | Pharmacia & Upjohn Company Llc | Oxazolidinone amidoximes as antibacterial agents |
| WO2005082897A1 (en) * | 2004-01-28 | 2005-09-09 | Pharmacia & Upjohn Company Llc | Oxazolidinone antibacterial agents |
| WO2005085266A2 (en) | 2004-02-27 | 2005-09-15 | Rib-X Pharmaceuticals, Inc. | Macrocyclic compounds and methods of making and using the same |
| DE102004062475A1 (de) * | 2004-12-24 | 2006-07-06 | Bayer Healthcare Ag | Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung |
| EP1685841A1 (en) | 2005-01-31 | 2006-08-02 | Bayer Health Care Aktiengesellschaft | Prevention and treatment of thromboembolic disorders |
| AU2006231919A1 (en) | 2005-04-06 | 2006-10-12 | Pharmacia & Upjohn Company Llc | 7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents |
| JP2009506063A (ja) * | 2005-08-24 | 2009-02-12 | リブ−エックス ファーマシューティカルズ，インコーポレイテッド | トリアゾール化合物ならびにこれを作製する方法および使用する方法 |
| DK1934238T3 (en) | 2005-08-24 | 2017-09-18 | Melinta Therapeutics Inc | TRIAZOL COMPOUNDS AND METHODS FOR THE PREPARATION AND USE OF THESE |
| DE102005045518A1 (de) | 2005-09-23 | 2007-03-29 | Bayer Healthcare Ag | 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung |
| DE502006009169D1 (en) | 2005-10-04 | 2011-05-05 | Bayer Schering Pharma Ag | NEUE POLYMORPHE FORM VON 5-CHLOR-N-(ä ( 5S )-2-0X0-3-Ä4-( 3-OXO-4-MORPHOLINYL)-PHENYLÜ-1,3-OXAZOLIDIN-5-YLü -METHYL)-2-THIOPHENCARBOXAMID |
| DE102005047558A1 (de) * | 2005-10-04 | 2008-02-07 | Bayer Healthcare Ag | Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen |
| DE102005047561A1 (de) | 2005-10-04 | 2007-04-05 | Bayer Healthcare Ag | Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung |
| US7649007B2 (en) * | 2006-08-15 | 2010-01-19 | Wyeth Llc | Oxazolidine derivatives as PR modulators |
| WO2008021337A1 (en) | 2006-08-15 | 2008-02-21 | Wyeth | Oxazinan-2-one derivatives useful as pr modulators |
| US7652018B2 (en) * | 2006-08-15 | 2010-01-26 | Wyeth Llc | Imidazolidin-2-one derivatives useful as PR modulators |
| TW200815428A (en) | 2006-08-15 | 2008-04-01 | Wyeth Corp | Oxazolidone derivatives as PR modulators |
| DE102006051625A1 (de) * | 2006-11-02 | 2008-05-08 | Bayer Materialscience Ag | Kombinationstherapie substituierter Oxazolidinone |
| WO2008143649A2 (en) * | 2006-12-04 | 2008-11-27 | Dr. Reddy's Laboratories Limited | Novel oxazolidinone compounds as antiinfective agents |
| TWI429643B (zh) * | 2008-02-22 | 2014-03-11 | Actelion Pharmaceuticals Ltd | 唑啶酮衍生物 |
| WO2018170664A1 (en) * | 2017-03-20 | 2018-09-27 | Merck Sharp & Dohme Corp. | Oxazolidinone compounds and methods of use thereof as antibacterial agents |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4705799A (en) | 1983-06-07 | 1987-11-10 | E. I. Du Pont De Nemours And Company | Aminomethyl oxooxazolidinyl benzenes useful as antibacterial agents |
| US5032605A (en) * | 1987-10-09 | 1991-07-16 | Du Pont Merck Pharmaceutical Company | Aminomethyl oxooxazolidinyl oxa or thia cycloalkylbenzene derivatives useful as antibacterial agents |
| US4965268A (en) * | 1987-10-09 | 1990-10-23 | E. I. Du Pont De Nemours And Company | Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents |
| US4801600A (en) | 1987-10-09 | 1989-01-31 | E. I. Du Pont De Nemours And Company | Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents |
| US4942183A (en) * | 1987-10-16 | 1990-07-17 | E. I. Du Pont De Nemours And Company | Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents |
| CA1320730C (en) | 1987-10-16 | 1993-07-27 | The Du Pont Merck Pharmaceutical Company | Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents |
| US5254577A (en) | 1988-07-29 | 1993-10-19 | The Du Pont Merck Pharmaceutical Company | Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents |
| US4948801A (en) * | 1988-07-29 | 1990-08-14 | E. I. Du Pont De Nemours And Company | Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents |
| DE68929303T2 (de) | 1988-09-15 | 2002-05-02 | Pharmacia & Upjohn Co., Kalamazoo | 3-(Stickstoff substituierte)phenyl-5-beta-amidomethyloxazoliden-2-one |
| US5164510A (en) * | 1988-09-15 | 1992-11-17 | The Upjohn Company | 5'Indolinyl-5β-amidomethyloxazolidin-2-ones |
| JP2669579B2 (ja) * | 1991-10-23 | 1997-10-29 | エーザイ株式会社 | オキサゾリドン誘導体 |
| DE4303303C1 (de) | 1993-02-05 | 1994-02-17 | Freudenberg Carl Fa | Antriebsstrang eines Kraftfahrzeugs |
| DE4332384A1 (de) | 1993-09-23 | 1995-03-30 | Merck Patent Gmbh | Adhäsionsrezeptor-Antagonisten III |
| TW286317B (es) | 1993-12-13 | 1996-09-21 | Hoffmann La Roche | |
| DE4425613A1 (de) | 1994-07-20 | 1996-01-25 | Bayer Ag | 5-gliedrige Heteroaryl-oxazolidinone |
| DE4425609A1 (de) * | 1994-07-20 | 1996-01-25 | Bayer Ag | Benzofuranyl- und Benzothienyloxazolidinone |
| DE4425612A1 (de) | 1994-07-20 | 1996-04-04 | Bayer Ag | 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone |
| DE19514313A1 (de) * | 1994-08-03 | 1996-02-08 | Bayer Ag | Benzoxazolyl- und Benzothiazolyloxazolidinone |
| HRP960159A2 (en) | 1995-04-21 | 1997-08-31 | Bayer Ag | Benzocyclopentane oxazolidinones containing heteroatoms |
-
1996
- 1996-02-06 DE DE19604223A patent/DE19604223A1/de not_active Withdrawn
-
1997
- 1997-01-27 HR HR19604223.2A patent/HRP970048A2/hr not_active Application Discontinuation
- 1997-01-31 PT PT97101509T patent/PT789025E/pt unknown
- 1997-01-31 DK DK97101509T patent/DK0789025T3/da active
- 1997-01-31 SI SI9730110T patent/SI0789025T1/xx unknown
- 1997-01-31 DE DE59703261T patent/DE59703261D1/de not_active Expired - Fee Related
- 1997-01-31 EP EP97101509A patent/EP0789025B1/de not_active Expired - Lifetime
- 1997-01-31 AT AT97101509T patent/ATE200285T1/de not_active IP Right Cessation
- 1997-01-31 ES ES97101509T patent/ES2157027T3/es not_active Expired - Lifetime
- 1997-02-03 IL IL12012597A patent/IL120125A0/xx unknown
- 1997-02-03 US US08/794,034 patent/US5792765A/en not_active Expired - Fee Related
- 1997-02-03 NZ NZ314179A patent/NZ314179A/xx unknown
- 1997-02-04 AR ARP970100439A patent/AR005703A1/es unknown
- 1997-02-04 BG BG101193A patent/BG101193A/xx unknown
- 1997-02-04 ID IDP970341A patent/ID15881A/id unknown
- 1997-02-04 TW TW086101259A patent/TW350845B/zh active
- 1997-02-04 AU AU12516/97A patent/AU1251697A/en not_active Abandoned
- 1997-02-04 MX MX9700886A patent/MX9700886A/es unknown
- 1997-02-04 TN TNTNSN97032A patent/TNSN97032A1/fr unknown
- 1997-02-04 PL PL97318277A patent/PL318277A1/xx unknown
- 1997-02-05 NO NO970511A patent/NO970511L/no unknown
- 1997-02-05 CZ CZ97340A patent/CZ34097A3/cs unknown
- 1997-02-05 TR TR97/00092A patent/TR199700092A2/xx unknown
- 1997-02-05 KR KR1019970003610A patent/KR970061888A/ko not_active Application Discontinuation
- 1997-02-05 YU YU4397A patent/YU4397A/sh unknown
- 1997-02-05 EE EE9700043A patent/EE9700043A/xx unknown
- 1997-02-05 ZA ZA9700927A patent/ZA97927B/xx unknown
- 1997-02-05 CA CA002196862A patent/CA2196862A1/en not_active Abandoned
- 1997-02-05 SK SK158-97A patent/SK15897A3/sk unknown
- 1997-02-05 SG SG1997000259A patent/SG50791A1/en unknown
- 1997-02-05 BR BR9700885A patent/BR9700885A/pt not_active Application Discontinuation
- 1997-02-05 HU HU9700358A patent/HUP9700358A3/hu unknown
- 1997-02-06 SV SV1997000009A patent/SV1997000009A/es unknown
- 1997-02-06 CN CN97101879A patent/CN1160051A/zh active Pending
- 1997-02-06 CO CO97006151A patent/CO4560411A1/es unknown
- 1997-02-06 JP JP9036908A patent/JPH09316073A/ja active Pending
-
2001
- 2001-06-08 GR GR20010400867T patent/GR3036015T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG101193A (en) | New substituted oxazolidinons | |
| BG101194A (en) | New heteroaryl oxazolidinons | |
| BG101139A (en) | Heteroatoms-containing cyclopentanopyridyloxazolidinons | |
| ZA972727B (en) | A novel composition, its preparation and use. | |
| BG101131A (en) | 2-oxo-and 2-thio-1,2-dihydroquinolinyl-oxazolidinons | |
| ZA977695B (en) | 1,4-heterocyclic metalloprotease inhibitors. | |
| AU2957997A (en) | 1,2,4-oxadiazoles as adhesion-receptor antagonists | |
| ZA97223B (en) | Lubricating compositions. | |
| ZA978178B (en) | Composition. | |
| ZA977693B (en) | 1,3-diheterocyclic metalloprotease inhibitors. | |
| BG103251A (en) | Oxydiazols, methods for their preparation and application as medicamentous forms | |
| EP0670647A3 (en) | Facility for real-time translation of administrative data. | |
| BG103219A (en) | Benzamidine derivatives and their application as medicamentous forms with ltb-4-antagonist effect | |
| PH30781A (en) | Papermaking compositions, process using same, and paper produced therefrom. | |
| ZA964711B (en) | Novel compounds, the preparation and use thereof. | |
| ZA975261B (en) | Composition. | |
| ZA972056B (en) | Substituted 1,2,3,4-tetrahydronaphthalene derivatives. | |
| HK1019757A1 (en) | Synthetic polysaccharides, preparation method therefor and pharmaceutical compositions containing same. | |
| EP0670117A3 (en) | Food composition with low buffering capacity. | |
| ZA9710542B (en) | Modified 1,3-propanediol-based polyesters. | |
| BG104232A (en) | Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazozocyn-10-ols, method for their preparation and application as medicamentous forms | |
| BG101401A (en) | Cisaspide extended release oral compositions | |
| ZA979670B (en) | Piperazino derivatives as neurokinin antagonists. | |
| BG102771A (en) | Diarylmethylidenfuran derivatives, method for their preparation and utilization as medicamentous forms | |
| BG102213A (en) | Endoparasiticidic composition based on didepsipeptides, new didepsipeptides and method for their preparation |